These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9004445)

  • 1. A new family of carriers (biovectors) enhances the immunogenicity of rabies antigens.
    Castignolles N; Morgeaux S; Gontier-Jallet C; Samain D; Betbeder D; Perrin P
    Vaccine; 1996 Oct; 14(14):1353-60. PubMed ID: 9004445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isatis indigotica root polysaccharides as adjuvants for an inactivated rabies virus vaccine.
    Zhang W; Zheng X; Cheng N; Gai W; Xue X; Wang Y; Gao Y; Shan J; Yang S; Xia X
    Int J Biol Macromol; 2016 Jun; 87():7-15. PubMed ID: 26875535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chimeric rabies virus-like particles containing membrane-anchored GM-CSF enhances the immune response against rabies virus.
    Kang H; Qi Y; Wang H; Zheng X; Gao Y; Li N; Yang S; Xia X
    Viruses; 2015 Mar; 7(3):1134-52. PubMed ID: 25768031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction and immunogenicity of a recombinant pseudotype baculovirus expressing the glycoprotein of rabies virus in mice.
    Huang H; Xiao S; Qin J; Jiang Y; Yang S; Li T; Gao Y; Li Z; Li T; Su X; Ruan Y; Xu F; Wang H; Chen H; Xia X
    Arch Virol; 2011 May; 156(5):753-8. PubMed ID: 21221673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A CpG oligodeoxynucleotide enhances the immune response to rabies vaccination in mice.
    Yu P; Yan J; Wu W; Tao X; Lu X; Liu S; Zhu W
    Virol J; 2018 Nov; 15(1):174. PubMed ID: 30424815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A CpG oligodeoxynucleotide acts as a potent adjuvant for inactivated rabies virus vaccine.
    Wang X; Bao M; Wan M; Wei H; Wang L; Yu H; Zhang X; Yu Y; Wang L
    Vaccine; 2008 Mar; 26(15):1893-901. PubMed ID: 18321616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced Immune Response to Rabies Viruses by the Use of a Liposome Adjuvant in Vaccines.
    Miao L; Yang Y; Yan M; Li Y; Zhao J; Guo J; Zheng D
    Viral Immunol; 2017 Dec; 30(10):727-733. PubMed ID: 28953450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the immunogenicity of two inactivated recombinant rabies viruses overexpressing the glycoprotein.
    Navid MT; Li Y; Zhou M; Cui M; Fu ZF; Tang L; Zhao L
    Arch Virol; 2016 Oct; 161(10):2863-70. PubMed ID: 27438075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein gene.
    Cenna J; Tan GS; Papaneri AB; Dietzschold B; Schnell MJ; McGettigan JP
    Vaccine; 2008 Nov; 26(50):6405-14. PubMed ID: 18804506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there an advantage to including the nucleoprotein in a rabies glycoprotein subunit vaccine?
    Drings A; Jallet C; Chambert B; Tordo N; Perrin P
    Vaccine; 1999 Mar; 17(11-12):1549-57. PubMed ID: 10195792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addition of C3d-P28 adjuvant to a rabies DNA vaccine encoding the G5 linear epitope enhances the humoral immune response and confers protection.
    Galvez-Romero G; Salas-Rojas M; Pompa-Mera EN; Chávez-Rueda K; Aguilar-Setién Á
    Vaccine; 2018 Jan; 36(2):292-298. PubMed ID: 29191739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune responses of mice to inactivated rabies vaccine administered orally: potentiation by Quillaja saponin.
    Maharaj I; Froh KJ; Campbell JB
    Can J Microbiol; 1986 May; 32(5):414-20. PubMed ID: 3719460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of a novel nanoemulsion adjuvant for rabies vaccine which stabilizes a Krebs cycle intermediate (SDH) in an animal model.
    Ze L; Zonglin L; Ya'Nan W; Shaohui S; Huijuan Y; Wei C; Li W; Liao G
    Hum Vaccin Immunother; 2019; 15(2):388-396. PubMed ID: 30299210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of G2 Citric Acid-Based Dendrimer as an Adjuvant in Veterinary Rabies Vaccine.
    Asgary V; Shoari A; Afshar Moayad M; Shafiee Ardestani M; Bigdeli R; Ghazizadeh L; Khosravy MS; Panahnejad E; Janani A; Bashar R; Abedi M; Ahangari Cohan R
    Viral Immunol; 2018; 31(1):47-54. PubMed ID: 29328884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of antibody production against rabies virus by uridine 5'-triphosphate in mice.
    Iwaki Y; Sakai Y; Ochiai K; Umemura T; Sunden Y
    Microbes Infect; 2014 Mar; 16(3):196-202. PubMed ID: 24309427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rabies DNA vaccine encoding lysosome-targeted glycoprotein supplemented with Emulsigen-D confers complete protection in preexposure and postexposure studies in BALB/c mice.
    Kaur M; Saxena A; Rai A; Bhatnagar R
    FASEB J; 2010 Jan; 24(1):173-83. PubMed ID: 19741168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanogram quantities of plasmid DNA encoding the rabies virus glycoprotein protect mice against lethal rabies virus infection.
    Ray NB; Ewalt LC; Lodmell DL
    Vaccine; 1997 Jun; 15(8):892-5. PubMed ID: 9234541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A DNA vaccine that encodes rabies virus glycoprotein lacking transmembrane domain enhances antibody response but not protection.
    Gupta PK; Sharma S; Walunj SS; Patil AA; Rai A; Saini M
    Acta Virol; 2006; 50(2):87-92. PubMed ID: 16808325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of antigen-specific interleukin 2 production by adding liposomes to rabies antigens for priming.
    Mansour S; Thibodeau L; Perrin P; Sureau P; Mercier G; Joffret ML; Oth D
    Immunol Lett; 1988 May; 18(1):33-6. PubMed ID: 3259943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical Development of Inactivated Rabies Virus-Based Polyvalent Vaccine Against Rabies and Filoviruses.
    Willet M; Kurup D; Papaneri A; Wirblich C; Hooper JW; Kwilas SA; Keshwara R; Hudacek A; Beilfuss S; Rudolph G; Pommerening E; Vos A; Neubert A; Jahrling P; Blaney JE; Johnson RF; Schnell MJ
    J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S414-24. PubMed ID: 26063224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.